Inhibition of glucose uptake in murine cardiomyocyte cell line HL-1 by cardioprotective drugs dilazep and dipyridamole

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 286, Issue 2 55-2, 2004, Pages

  Shuralyova, Irina ^a   Tajmir, Panteha ^a   Bilan, Philip J ^b   Sweeney, Gary ^a   Coe, Imogen R ^a  

^a YORK UNIVERSITY   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Adenosine; Equilibrative nucleoside transporters; Regulation

Indexed keywords

2 CHLOROADENOSINE; ADENOSINE; ADENOSINE DERIVATIVE; ADENOSINE RECEPTOR; DILAZEP; DIPYRIDAMOLE; GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; INSULIN; NITROBENZYLTHIOINOSINE;

ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; CELL LYSATE; CONTROLLED STUDY; GLUCOSE TRANSPORT; HEART MUSCLE CELL; HEART PROTECTION; IMMUNOBLOTTING; MOUSE; NONHUMAN; NUCLEOSIDE TRANSPORT; PARACRINE SIGNALING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; REGULATORY MECHANISM;

EID: 0942265668     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00639.2003     Document Type: Article

References (59)

1. Angello DA, Berne RM, and Coddington NM. Adenosine and insulin mediate glucose uptake in normoxic rat hearts by different mechanisms. Am J Physiol Heart Circ Physiol 265: H880-H885, 1993.
2. Bailey A, Matthes H, Kieffer B, Slowe S, Hourani SMO, and Kitchen I. Quantitative autoradiography of adenosine receptors and NBTI-sensitive adenosine transporters in the brains and spinal cords of mice deficient in the μ-opioid receptor gene. Brain Res 943: 68-79, 2002.
3. Becker C, Sevilla L, Tomas E, Palacin M, Zorzano A, and Fischer Y. The endosomal compartment is an insulin-sensitive recruitment site for GLUT4 and GLUT1 glucose transporters in cardiac myocytes. Endocrinology 142: 5267-5276, 1989.
4. Bednarczyk D, Ekins S, Wikel JH, and Wright SH. Influence of molecular structure on substrate binding to the human organic cation transporter, hOCT1. Mol Pharmacol 63: 489-498, 2003.
5. Belardinelli R, Belardinelli L, and Shyrock JC. Effects of dipyridamole on coronary collateralization and myocardial perfusion in patients with ischaemic cardiomyopathy. Eur Heart J 22: 1205-1213, 2001.
6. Bendayan R. Interaction of dipyridamole, a nucleoside transport inhibitor, with the renal transport of organic cations by LLCPK 1 cells. Can J Physiol Pharmacol 75: 52-56, 1997.
7. Bergmann C, Loken C, Becker C, Graf B, Hamidizadeh M, and Fischer Y. Inhibition of glucose transport by cyclic GMP in cardiomyocytes. Life Sci 69: 1391-1406, 2001.
8. Bertuglia S, Giusti A, Fedele S, and Picano E. Glucose-insulin-potassium treatment in combination with dipyridamole inhibits ischaemia-reperfusion-induced damage. Diabetologia 44: 2165-2170, 2001.
9. Chaudary N, Shuralyova I, Liron T, Sweeney G, and Coe IR. Transport characteristics of HL-1 cells: a new model for the study of adenosine physiology in cardiomyocytes. Biochem Cell Biol 80: 655-665, 2002.
10. Claycomb WC, Lanson NA, Stallworth BS, Egeland DB, Delcarpio JB, Bahinski A, and Izzo NJ. HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci USA 95: 2979-2984, 1998.
11. 6-(L-2-phenylisopropyl) adenosine. Circ Res 69: 791-799, 1991.
12. De Jong JW, de Jonge R, Keijzer E, and Bradamante S. The role of adenosine in preconditioning. Pharmacol Ther 87: 141-149, 2000.
13. De SC, Algra A, and Van Gijn J. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease (Cochrane Review). Cochrane Database Sys Rev CD001820, 2003.
14. De La Cruz JP, Blanco E, and Sanchez de la Cuesta F. Effect of dipyridamole and aspirin on the platelet neutrophil interaction via the nitric oxide pathway. Eur J Pharmacol 397: 35-40, 2000.
15. Deng XF, Rokosh DG, and Simpson PC. Autonomous and growth factor-induced hypertrophy in cultured neonatal mouse cardiac myocytes: comparison with rat. Circ Res 87: 781-788, 2000.
16. Derave W and Hespel P. Role of adenosine in regulating glucose uptake during contractions and hypoxia in rat skeletal muscle. J Physiol 515: 255-263, 1999.
17. Deussen A. Cardiac adenosine metabolism: physiological implications. In: Purines and Myocardial Protection, edited by Wechsler ASA. Boston, MA: Kluwer, 1996.
18. Deussen A. Metabolic flux rates of adenosine in the heart. Naunyn-Schmeidberg's Arch Pharmacol 362: 351-363, 2000.
19. Deussen A. Quantitative integration of different sites of adenosine metabolism in the heart. Ann Biomed Eng 28: 877-883, 2000.
20. Eblenkamp M, Bottcher U, Thomoas J, Loken C, Ionescu I, Rose H, Kammermeier H, and Fischer Y. The effect of anoxia on cardiomyocyte glucose transport does not involve an adenosine release or a change in energy state. Life Sci 59: 141-151, 1996.
21. Figueredo VM, Diamond I, Zhou HZ, and Camacho SA. Chronic dipyridamole therapy produces sustained protection against cardiac ischemic-reperfusion injury. Am J Physiol Heart Circ Physiol 277: H2091-H2097, 1999.
22. Fischer Y, Becker C, and Loken C. Purinergic inhibition of glucose transport in cardiomyocytes. J Biol Chem 274: 755-761, 1999.
23. Guideri F, Capecchi PL, Acampa M, Cuomo A, Lazzerini PE, Giorgi LD, and Pasini FL. Oral low-dose dipyridamole protects from intravenous high-dose dipyridamole-induced ischemia. A stress echocardiographic study. Int J Cardiol 83: 209-216, 2002.
24. Han DH, Hansen PA, Nolte LA, and Holloszy JO. Removal of adenosine decreases the responsiveness of muscle glucose transport to insulin and contractions. Diabetes 47: 1671-1675, 1998.
25. Headrick JP. Ischemic preconditioning: bioenergetic and metabolic changes, and the role of endogenous adenosine. J Mol Cell Cardiol 27: 1041-1054, 1996.
26. Hyde RJ, Cass CE, Young JD, and Baldwin SA. The ENT family of eukaryote nucleoside and nucleobase transporters: recent advances in the investigation of structure/function relationships and the identification of novel isoforms. Mol Membr Biol 18: 53-63, 2001.
27. Hruz PW, Murata H, Qiu H, and Mueckler M. Indinavir induces acute and reversible peripheral insulin resistance in rats. Diabetes 51: 937-942.
28. James DE, Strube M, and Mueckler M. Molecular cloning and characterization of an insulin-regulatable glucose transporter. Nature 338: 83-87, 1989.
29. Joost HG and Thorens B. The extended GLUT-family of sugar/polyol transport facilitators: nomenclature, sequences characteristics, and potential function of its novel members. Mol Membr Biol 18: 247-256, 2001.
30. Joost HG, Weber TM, Cushman SW, and Simpson IA. Insulin-stimulated glucose transport in rat adipose cells. Modulation of transporter intrinsic activity by isoproterenol and adenosine. J Biol Chem 261: 10033-10036, 1986.
31. Koivisto UM, Martinez-Valdez H, Bilan PJ, Burdett E, Ramlal T, and Klip A. Differential regulation of the GLUT-1 and GLUT-4 glucose transport systems by glucose and insulin in L6. J Biol Chem 266: 2615-2621, 1991.
32. Law WR and Raymond RM. Adenosine potentiates insulin-stimulated myocardial glucose uptake in vivo. Am J Physiol Heart Circ Physiol 254: H970-H975, 1988.
33. Liang BT, Swierkosz TA, Herrmann HC, Kimmel S, and Jacobsen KA. Adenosine and ischemic preconditioning. Curr Pharm Des 5: 1029-1041, 1999.
34. Mainwaring R, Lasley R, Rubio R, Wyatt DA, and Mentzer RM Jr. Adenosine stimulates glucose uptake in the isolated rat heart. Surgery 103: 445-449, 1998.
35. Marzilli M, Trivella MG, Levantesi D, Pelosi G, Dalle Vacche M, Taddei L, and L'Abbate A. Effect of dilazep on coronary and systemic circulations. Pharmacology 31: 82-87, 1985.
36. Murata H, Hruza PW, and Mueckler M. Indinavir inhibits the glucose transporter isoform Glut4 at physiologic concentrations. AIDS 16: 859-863, 2002.
37. Nakamura K, Kojima K, Arai T, Shirai M, Usutani S, Akimoto H, Masaoka H, Nagase M, and Yamamoto M. Dipyridamole and dilazep suppress oxygen radicals in puromycin aminonucleoside nephrosis rats. Eur J Clin Invest 28: 877-888, 1998,
38. Neilan CL, Kenyon E, Kovach MA, Bowden K, Claycomb WC, Traynor JR, and Bolling SF. An immortalized myocyte cell line, HL-1, expresses a functional 8-opioid receptor. J Mol Cell Cardiol 32: 2187-2193, 2000.
39. Nguyen SU and Claycomb WC. Hypoxia regulates the expression of the adrenomedullin and HIF-1 genes in cultured HL-1 cardiomyocytes. Biochem Biophys Res Commun 265: 382-386, 1999.
40. Pao SS, Paulsen IT, and Saier MH Jr. Major facilitator superfamily. Microbiol Mol Biol Rev 62: 1-34, 1998.
41. Pelleg A, Pennock RS, and Kutalek SP. Proarrhythmic effects of adenosine: one decade of clinical data. Am J Ther 9: 141-147, 2002.
42. Picano E. Dipyridamole in myocardial ischemia: good Samaritan or terminator? Int J Cardiol 83: 215-216, 2002.
43. Plagemann PGW and Woffendin C. Species differences in sensitivity of nucleoside transport in erythrocytes and cultured cells to inhibition by nitrobenzylthioinosine, dipyridamole, dilazep and lidoflazine. Biochim Biophys Acta 969: 1-8, 1988.
44. Pouzet B, Lecharny JB, Dehoux M, Paquin S, Kitazake M, Mantz J, and Menasche P. Is there a place for preconditioning during cardiac operations in humans? Ann Thorac Surg 73: 843-848, 2002.
45. Ruggiero AC, Neopmuceno MF, Jacob RF, Dorta DJ, and Tabak M. Antioxidant effect of dipyrdamole (DIP) and its derivative RA 25 upon lipid peroxidation and hemolysis in red blood cells. Physiol Chem Phys Med NMR 32: 35-48, 2000.
46. Sargeant RJ and Paquet MR. Effect of insulin on the rates of synthesis and degradation of GLUT1 and GLUT4 glucose transporters in 3T3-L1 adipocytes. Biochem J 290: 913-919, 1993.
47. Soltys CLM, Buchholz L, Gandhi M, Clanachan AS, Walsh K, and Dyck JRB. Phosphorylation of cardiac protein kinase B is regulated by palmitate. Am J Physiol Heart Circ Physiol 283: H1056-H1064, 2002.
48. Sumitani S, Ramlal T, Somwar R, Keller SR, and Klip A. Insulin regulation and selective segregation with glucose transporter-4 of the membrane aminopeptidase vp165 in rat skeletal muscle cells. Endocrinology 138: 1029-1034, 1997.
49. + current in human airway epithelial cells by exogenous and autocrine adenosine. Am J Physiol Cell Physiol 281: C1991-C2002, 2001.
50. Takasuga S, Katada T, Ui M, and Hazeku O. Enhancement by adenosine of insulin-induced activation of phosphoinositide 3-kinase and protein kinase B in rat adipocytes. J Biol Chem 274: 19545-19550, 1999.
51. Talbert RL and Crawford KM. Antiplatelet therapy in secondary stroke prevention. Exp Op Pharm 2: 1609-1613, 2001.
52. Thong FS and Graham TE. The putative roles of adenosine in insulin- and exercise-mediated regulation of glucose transport and glycogen metabolism in skeletal muscle. Can J Appl Physiol 27: 152-178, 2002.
53. Tommasi S, Carluccio E, Bentivoglio M, Corea L, and Picano E. Low-dose dipyridamole infusion acutely increases exercise capacity in angina pectoris: a double blind, placebo controlled crossover stress echocardiographic study. J Am Coll Cardiol 35: 83-88, 2000.
54. Torry RJ, O'Brien DM, Connell PM, and Tomanek RJ. Dipyridamole-induced capillary growth in normal and hypertrophic hearts. Am J Physiol Heart Circ Physiol 262: H980-H986, 1992.
55. Vergauwen L, Hespel P, and Richter EA. Adenosine receptors mediate synergistic stimulation of glucose uptake and transport by insulin and by contractions in rat skeletal muscle. J Clin Invest 93: 974-981, 1994.
56. Wakai A, Winter DC, Street JT, O'Sullivan RG, Wang JH, and Redmond HP. Inosine attenuates tourniquet-induced skeletal muscle reperfusion injury. J Surg Res 99: 311-315, 2001.
57. Walker PS, Ramlal T, Sarabia V, Koivisto UM, Bilan PJ, Pessin JF, and Klip A. Glucose transport activity in L6 muscle cells is regulated by the coordinate control of subcellular glucose transporter distribution, biosynthesis, and mRNA transcription. J Biol Chem 265: 1516-1523, 1990.
58. Yamasaki K, Tanaka M, Yokota R, Fujiwara H, and Sasayama S. Dilazep dihydrochloride prolongs the infarct size-limiting effect of ischemic preconditioning in rabbits. Heart Vessels 15: 227-232, 2000.
59. Yao H, Kristensen DM, Mihalek I, Sowa ME, Shaw C, Kimmel M, Kavraki L, and Lichtarge O. An accurate, sensitive and scalable method to identify functional sites in protein structures. J Mol Biol 326: 255-261, 2003.